Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom
Overview
Authors
Affiliations
Introduction: The externally validated Kidney Failure Risk Equation (KFRE) for predicting risk of end-stage renal disease (ESRD) has been developed, but its potential impact in a population on referrals for patients with chronic kidney disease (CKD) from primary to specialty nephrology care is not known.
Methods: A cross-sectional population-based study of individuals in United Kingdom primary care registered in The Health Improvement Network database was conducted. National Institute of Health and Care Excellence (NICE) 2014 CKD guidelines the 4-variable KFRE set at a >3% risk of ESRD at 5 years were applied to patients identified with CKD stage 3-5 between January 1, 2016, and March 31, 2017.
Results: In all, 39,476 (36.6%) of 107,962 adults with CKD stage 3-5 had a urine albumin:creatinine ratio (ACR) available and entered into the primary analysis. Of that, 7566 (19.2%) patients fulfilled NICE criteria for referral, 2386 (31.5%) of whom had a ≤3% 5-year risk of ESRD. Also 8663 (21.9%) patients had a >3% 5-year risk of ESRD, 3483 (40.2%) of whom did not fulfill NICE criteria; this represents 8.8% of the primary population. By using the KFRE threshold rather than NICE criteria for referral, 5869 patients (14.9% of the primary analysis population) would have been reallocated between primary and specialist care. Imputational analysis was used for missing ACR measurements and showed similar results.
Conclusions: A risk-based referral approach would lead to a substantial reallocation of patients between primary care and specialist nephrology care with only a small increase in numbers eligible, ensuring those at higher risk of progression are identified.
Bundo-Luque D, Cunillera-Puertolas O, Cobo-Guerrero S, Romano J, Arbiol-Roca A, Dominguez-Alonso J Front Med (Lausanne). 2025; 11:1497780.
PMID: 39944820 PMC: 11813909. DOI: 10.3389/fmed.2024.1497780.
Janse R, Stel V, Jager K, Tripepi G, Zoccali C, Dekker F Nephrol Dial Transplant. 2024; 40(1):27-33.
PMID: 39020254 PMC: 11852334. DOI: 10.1093/ndt/gfae170.
Mutatiri C, Ratsch A, McGrail M, Venuthurupalli S, Chennakesavan S BMC Nephrol. 2024; 25(1):149.
PMID: 38689219 PMC: 11061991. DOI: 10.1186/s12882-024-03585-z.
Clinical Decision Support Tools in the Electronic Medical Record.
Alexiuk M, Elgubtan H, Tangri N Kidney Int Rep. 2024; 9(1):29-38.
PMID: 38312784 PMC: 10831391. DOI: 10.1016/j.ekir.2023.10.019.
Implementation of the Kidney Failure Risk Equation in a United States Nephrology Clinic.
Patel D, Churilla B, Thiessen-Philbrook H, Sang Y, Grams M, Parikh C Kidney Int Rep. 2023; 8(12):2665-2676.
PMID: 38106577 PMC: 10719573. DOI: 10.1016/j.ekir.2023.09.001.